Mealey's (June 15, 2018, 10:56 AM EDT) -- WASHINGTON, D.C. — A Texas federal magistrate judge’s sua sponte construction of “gelling agent” as excluding water was erroneous, the licensee and owner of a patent covering the ulcerative colitis drug Delzicol maintain in an appeal to the Federal Circuit U.S. Court of Appeals (Allergan Pharmaceuticals International Ltd., et al. v. Teva Pharmaceuticals USA Inc., et al., No. 18-1241, Fed. Cir.)....